Main Topics

• Origin of Antiphospholipid Antibodies
• Genetics of Antiphospholipid Antibodies/Syndrome
• Mechanism(s) of Antiphospholipid Antibody-mediated Thrombosis
• Mechanism(s) of Antiphospholipid Antibody-mediated Pregnancy Morbidity
• Target Cells and Receptors that Interact with Antiphospholipid Antibodies
• Definition, Epidemiology, and Natural History of Antiphospholipid Syndrome
• Impact of Antiphospholipid Syndrome in General Population with Thrombosis and Pregnancy Morbidity
• Association with Antiphospholipid Syndrome and Other Systemic Autoimmune Diseases (Systemic Lupus Erythematosis, Rheumatoid Arthritis)
• Microangiopathic and Catastrophic Antiphospholipid Syndrome
• Impact of Pediatric APS in Children with Thrombosis
• Clinical and Prognostic Significance of “Criteria” and “Non-criteria” Antiphospholipid Antibody Tests
• Strengths and Limitations of the Current Classification Criteria
• Disease Measurement Criteria in Antiphospholipid Syndrome
• Most Recent Strategies in the Treatment of Thrombosis in General Population
• Current Treatment strategies for Non-obstetric Antiphospholipid Syndrome
• Current Treatment strategies for Obstetric Antiphospholipid Syndrome
• Antiphospholipid Syndrome Treatment Trends (Ongoing and Planned Interventional Studies with New Generation Oral Anticoagulants, B-cell inhibition, Complement Inhibition, Hydroxychloroquine, Statins, Peptide Therapy, and others)
• Antiphospholipid Antibodies, Antiphospholipid Syndrome (APS), and Obstetric APS for Patients